Jumpstart Nova

About The Fund

Jumpstart Nova is an institutional and strategic seed fund operating within the Jumpstart Health Investors platform, specializing in the healthcare sector. Their investment focus is primarily on early-stage companies in various segments of the healthcare industry, including Health IT, Digital Health, Tech-enabled Services, Consumer Health and Wellness, and Medicaid Services. Jumpstart Nova aims to fund and support passionate and uniquely qualified founders who are committed to improving healthcare in America. Fostering innovation, Jumpstart Nova seeks to lower the cost of care for patients, enhance patient outcomes, and hasten the introduction of positive changes within the healthcare system. Their portfolio showcases a variety of startups developing innovative solutions across the healthcare landscape, ranging from virtual care for autoimmunity to predictive analytics for geriatric health. Jumpstart Nova's investment strategy involves committing capital between $100,000 and $5,000,000, with a 'sweet spot' of around $1,500,000 per investment, targeting stages from Pre-seed to Series B. Jumpstart Nova prides itself on being more than a mere source of capital. They take an engaged approach to investing, working closely with founders, offering strategic guidance, and leveraging an extensive network in the healthcare industry to build impactful healthcare businesses. Based in Nashville, Tennessee, and Los Angeles, California, the partners at Jumpstart Nova bring over a decade of experience in early-stage healthcare venture investing, having established a reputation with the launch of their historic Fund I. Their leadership team includes Marcus Whitney, Founder and Managing Partner, and Kathryne Cooper, MBA, General Partner, both of whom are recognized for their commitment to supporting underrepresented founders and sharing a vision of diverse-led innovation in healthcare.